Moderna’s Revenue by Segment (2018-2021)

Exclusive Data

You need the Pro Plan for unlimited access.

Pro Plan

$49 per month*

60% discount ends in:

00
Days
00
Hours
00
Mins.
00
Seconds

.

Download

About

This statistic highlights Moderna’s Revenue by Segment, split between Collaboration Revenue, Grant Revenue, and Product Sales, reported on a quarterly basis.
Subscribe to Pro or Enterprise plans to unlock this feature.
More information
Subscribe to Pro or Enterprise plans to unlock this feature.
Contact the Analyst
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on reddit
Share on facebook
Share on twitter
Share on linkedin
Share on email

Become a smarter investor today.

Access Business Quant for as low as $19/month

Become a smarter investor today.

Access KPIs & Segment Financials on US stocks

This statistic highlights Moderna’s Revenue by Segment, split between Collaboration Revenue, Grant Revenue, and Product Sales, reported on a quarterly basis.

Moderna’s Revenue by Segment

Revenue by Segment  Q3 2020  Q2 2021  Q3 2021 Contribution in Q3 2021
Collaboration Revenue  $12.0   $18.0  $19.0 0.40%
Grant revenue  $145.0  $139.0  $140.0 2.80%
Product Sales  $4,197.0  $4,810.0 97%
Total  $1,937.0  $4,354.0  $4,969.0 100.0%

(All figures are in millions, except percentages)

Collaboration Revenue

Moderna Inc. has developed many medicines including strategic alliances with AstraZeneca, Merck & Co. Inc, and Vertex Pharmaceuticals Inc. discovering, developing, and commercializing potential mRNA medicines. The company made many collaborations including development services, research, licenses, and certain ways to obtain the development and commercialization rights and other related services and products. These all arrangements generate revenue through upfront fees, commercial milestone payments, royalties, licensing fees, option exercise fees, and other types of payments.

In Q3 2020, the segment earned $12 million, which rose to $19 million in Q3 2021, indicating a year-on-year growth of 58.33%. The company also made progress in the collaboration revenue segment and earned $19 million from Collaboration Revenue Segment (in Q3 2021) which contributed 0.4% to the total revenue of the company.

Grant Revenue

Grant Revenue Segment contributes 2.8% of the total revenue of Moderna Inc. generates moderate revenue through grants with various government-sponsored and private organizations. The company has established some contracts with the Biomedical Advanced Research and Development Authority (BARDA), the U.S. government’s Defense Advanced Research Projects Agency (DARPA), the Bill & Melinda Gates Foundation, and also from other organizations.

In Q3 2020, the segment earned $145 million which decreased to $140 million in Q3 2021, indicating a year-on-year fall of 3.44%. The company continued to earn revenue from the grant revenue segment even in the Coronavirus pandemic. In Q3 2021, Grant Segment generated $1.40 billion in revenue and contributed 2.8% to the total revenue of the Moderna company.

Product Sale

Product Sale is one of the highest-earning segments in Moderna Incorporation. it contributes around 95% to the total revenue of the company. This segment includes revenue generated through the sae of different products or medicines created by the company. it includes most famous called mRNA (Messenger RNA), this medicine performs the role in human body and transfer proteins in every cell where ever needed.

In Q2 2021, the segment earned $4197 million which increased to $4,810 million in Q3 2021, this segment contributed 96.8% in total revenue. This segment’s earning increased during the pandemic after receiving vaccine approval from the U.S. Food and Drug Administration FDA and Health Canada in December 2020. Moderna Inc. recently has seen its product sales explode after developing and winning government approval for an mRNA vaccine to protect against COVID-19.

About the Company

Moderna Inc. is a public and American company. It was founded in September 2010. It is a pharmaceutical and biotechnological based company situated in Cambridge. It operates as a clinical-stage biotechnology company. Moderna Incorporation focuses on the creation and development of the most successful medicine mRNA therapeutics and all the vaccines. Moderna Incorporation’s medicine MRNA is used for infectious, immuno-oncology, and cardiovascular diseases. The company has approximately 44 treatment, vaccine candidates, among which 21 vaccines had gone under the clinical trials.

The company has created an official website where customers can know about the schemes, new launches, and the latest information updated by the company. Moderna Incorporation deals with many customers around the globe and seeks for best services. The company’s mission is to develop medicines and cure the society and also prevent from diseases.

Did you like Moderna’s Revenue by Segment statistic?

Access more such KPI data points and segment financials on thousands of US stocks, with Business Quant.

You can get started here.

Read more

Access Segment financials and KPI data on US stocks

Our Plans

Always know what you’ll pay. No hidden costs or surprises.

  • Annual
  • Monthly

Basic

Get to know us

  • Access only basic data
  • This statistic is not included The statistic that you're currently viewing, is not included in the Basic plan. Please subscribe to the Pro plan to access this statistic.
$0
per month
Start for Free

60% discount until May 31

Pro

For serious investing

  • This statistic is included Instant access to all the data and features on the Business Quant platform. This also includes access to the statistic that you're currently viewing.
  • Granular KPI data Access segment financials, non-GAAP metrics and KPI data from presentations and filings. Examples include financials by segment / region / product category, AT&T's broadband subscriber trends, Tesla's deliveries by model and lots more.
  • Stock research tools Features include : Stock screener, Stock comparison, sector financials, stock warnings, advanced charting tools, financial statements dating back 10+ years, stock reports, SEC filings and stock ratings. There are 200+ financial items and ratios on thousands of US stocks.
  • Industry data & tools Access premium operating data on 40+ industries. Examples include market share, smartphone shipments by vendor, subscribers by wireless carrier, historical gold production. There are 20,000+ such statistics.
$49
$19
per month*
Buy Now

Enterprise

For tailored workflows

  • All of Pro plan Get unfettered access to all our dashboards and dossiers.
  • Custom built features Get tailored dashboards built specially for you , based on your set of requirements, to simplify your research workflow.
$99
per month, onwards*
Contact Us

* Billed annually, local taxes extra. 

Basic

Get to know us

  • Access only basic data
  • This statistic is not included The statistic that you're currently viewing, is not included in the Basic plan. Please subscribe to the Pro plan to access this statistic.
$0
per month
Start for Free

60% discount on Annual plan

Pro

For serious investing

  • This statistic is included Instant access to all the data and features on the Business Quant platform. This also includes access to the statistic that you're currently viewing.
  • Granular KPI data Access segment financials, non-GAAP metrics and KPI data from presentations and filings. Examples include financials by segment / region / product category, AT&T's broadband subscriber trends, Tesla's deliveries by model and lots more.
  • Stock research tools Features include : Stock screener, Stock comparison, sector financials, stock warnings, advanced charting tools, financial statements dating back 10+ years, stock reports, SEC filings and stock ratings. There are 200+ financial items and ratios on thousands of US stocks.
  • Industry data & tools Access premium operating data on 40+ industries. Examples include market share, smartphone shipments by vendor, subscribers by wireless carrier, historical gold production. There are 20,000+ such statistics.
$49
per month*
Buy Now

Enterprise

For tailored workflows

  • All of Pro plan Get unfettered access to all our features.
  • Custom built features Get tailored dashboards built specially for you , based on your set of requirements, to simplify your research workflow.
$99
per month, onwards*
Contact Us

* Local taxes extra. 

BQ Star Yellow 60%

Get Pro for 60% off

  • Access all features immediately
  • Datasets updated every day
  • Export data in CSV and XLSX formats

Offer Ends In

Starting from $49 $19 / month

.